Intraocular 9-([2-hydroxy-1-(hydroxymethyl) ethoxy] methyl) guanine levels after intravitreal and subconjunctival administration.

J. Schulman, G. A. Peyman, M. B. Horton, J. Liu, R. Fiscella, J. Pulido, J. C. Barber, P. de Miranda

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

Clearance studies in rabbits following intravitreal injection of 400 micrograms of 9-([2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl) guanine demonstrated levels of the antiviral at 60 hours above the in vitro ID50 for several strains of human cytomegalovirus. Intravitreal administration of this new antiviral may have therapeutic application in the treatment of acute retinal necrosis and cytomegalovirus retinitis complicating acquired immune deficiency syndrome (AIDS).

Original languageEnglish (US)
Pages (from-to)429-432
Number of pages4
JournalOphthalmic surgery
Volume17
Issue number7
StatePublished - Jul 1986

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Intraocular 9-([2-hydroxy-1-(hydroxymethyl) ethoxy] methyl) guanine levels after intravitreal and subconjunctival administration.'. Together they form a unique fingerprint.

  • Cite this

    Schulman, J., Peyman, G. A., Horton, M. B., Liu, J., Fiscella, R., Pulido, J., Barber, J. C., & de Miranda, P. (1986). Intraocular 9-([2-hydroxy-1-(hydroxymethyl) ethoxy] methyl) guanine levels after intravitreal and subconjunctival administration. Ophthalmic surgery, 17(7), 429-432.